/
IGNE
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2000 | 2001 | 2002 | 2003 | 2006 | 2007 | 2008 | 2009 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $702.5K | $4.2M | $3.5M | $463.5K | $0 | $2.3M | $7.6M | $4.0M |
| Cost of revenue | $691.2K | $3.5M | $3.2M | $446.1K | $0 | $1.7M | $6.4M | $2.9M |
| Gross profit | $11.4K | $663.6K | $324.1K | $17.3K | $0 | $605.1K | $1.2M | $1.0M |
| Gross margin | 1.6% | 15.9% | 9.3% | 3.7% | — | 26.5% | 16.3% | 25.7% |
| R&D | $355.7K | $536.6K | $609.8K | $745.4K | $847.6K | $983.6K | $1.7M | $1.9M |
| Operating income | −$1.5M | −$1.6M | −$1.9M | −$624.7K | −$416.5K | $237.9K | −$2.2M | −$1.1M |
| EBITDA | −$1.4M | −$1.5M | −$1.7M | −$541.0K | −$307.5K | $324.6K | −$2.1M | −$851.3K |
| Net income | −$2.3M | −$3.7M | −$3.2M | −$2.2M | −$1.2M | −$1.9M | −$4.0M | −$140.7K |
| Net margin | -321.0% | -87.8% | -91.4% | -474.5% | — | -83.0% | -52.2% | -3.6% |
| EPS (diluted) | -0.04 | -0.05 | -0.04 | -0.02 | -0.01 | -0.02 | -0.02 | -0.00 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.01
Price
$0.00
Implied upside
+1220770%
Peer comparison
IGENE BIOTECHNOLOGY INC
IGENE BIOTECHNOLOGY INC
Held by traders on TradeandTell
No one on the platform currently holds IGNE.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in IGNE as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded IGNE yet.